Peptide side effects
Every medication that does something can do something unwanted. These articles catalogue peptide side effects and those reported for GLP-1 medications — nausea, injection-site reactions, and the rarer things worth knowing about — plus what researchers report about how long effects last and what tends to help.
Honest side-effect information is a feature, not a liability: it's how you and your provider decide together whether a treatment fits. Where an effect has its own article — nausea, hair shedding, fatigue — you'll find the detail there.
37 articles on this topic
-

Semaglutide and Vision: What's Real, What's Rare
Most people never have an eye problem because of semaglutide. Two things do come up, though, and they get mixed together constantly — so here is what each one actually is.
-

Tirzepatide Diabetic Retinopathy: Who It's For
The tirzepatide diabetic retinopathy warning landed on both U.S. labels in August 2026. It asks for eye monitoring in people who already have the condition — not a finding that the medicine harms eyes.
-

Does Sermorelin Cause Hair Loss? Evidence Review
Current evidence does not identify hair loss as a sermorelin side effect. Growth hormone and IGF-1 affect follicles, but that biology cannot explain why one person starts shedding.
-

Kisspeptin Side Effects: What Human Trials Found
Short human trials suggest few systemic effects, while injection-site stinging can happen and repeated exposure can blunt the hormone response. The major unknown is long-term safety.
-

KLOW Peptide Side Effects: What the Evidence Shows
KLOW peptide side effects do not yet have reliable rates or a complete clinical list. The blend combines four peptides, so its clearest known risks are injection-site reactions, immune reactions, compounding-related problems, and effects that human studies have not measured.
-

Tirzepatide vs Semaglutide Side Effects
Neither medication has fewer side effects in every setting: dose, treatment population and the individual matter more than a simple ranking.
-

Does Semaglutide Cause Depression? What We Know
Large trials, cohort studies, and final FDA and European reviews have not found that semaglutide raises depression or suicidality risk. Individual mood changes still deserve prompt attention.
-

Foods to Avoid on Tirzepatide: A Practical Guide
There is no universal ban list. Smaller portions and fewer fried, high-fat, fizzy, or alcohol-heavy choices may make nausea, reflux, bloating, and fullness easier to manage.
-

Semaglutide and Pancreatitis: What Studies Show
Randomized trials have not shown more acute pancreatitis with semaglutide than with placebo, but the event is rare and remains a prescribing-label warning. Persistent, severe abdominal pain needs prompt medical attention.
-

Thymosin Alpha-1 Side Effects: What Trials Found
Published trials most consistently report local injection-site discomfort; fatigue and rash are uncommon and often hard to attribute. The limits are long-term exposure and the difference between studied thymalfasin and a compounded vial.
-

DSIP Side Effects: What Human Studies Found
Reported DSIP side effects include sleep pressure, headache, nausea, vertigo, sweating and occasional blood-pressure changes, but small, short studies leave long-term risk largely unknown.
-

Semaglutide Sulfur Burps: Why They Happen
Sulfur-smelling burps are a real but poorly measured digestive complaint with semaglutide. Trials counted belching, not its smell, and the likely explanation combines slower digestion with hydrogen-sulfide gas.
-

Tirzepatide Constipation: How Long It Lasts
Tirzepatide constipation is common, especially in the first weeks and after dose increases. It often eases as treatment stabilizes, while severe or persistent symptoms need a clinician’s attention.
-

Liraglutide vs Semaglutide: A Clear Comparison
Both are GLP-1 medicines, but liraglutide is usually injected daily and semaglutide weekly. Head-to-head trials show why the treatment goal and dose matter as much as the molecule.
-

Semaglutide Constipation: What Helps
Semaglutide constipation is common during initiation and dose escalation. It usually eases, but it can last longer than other stomach side effects and deserves a clear plan with the prescriber.
-

Tirzepatide Long-Term Side Effects: 3-Year Data
Three-year weight-management data and four-year cardiovascular data have not revealed a new late safety signal. They also do not tell us what decades of exposure will look like.
-

PT-141 Side Effects: What the Trials Found
PT-141 most often causes nausea, flushing, headache, and injection-site reactions. The safety questions that change screening are blood-pressure effects, skin darkening, and how little modern evidence exists for men.
-

Does Semaglutide Cause Muscle Loss?
Semaglutide-related weight loss can include a drop in lean mass, but DXA lean mass is not the same as skeletal muscle. STEP 1 found fat fell faster than lean tissue, improving lean mass as a share of body weight.
-

GHK-Cu Side Effects: Topical vs Injectable
GHK-Cu side effects are usually mild with topical cosmetics, but injectable GHK-Cu has no long-term human safety data. Route is the difference that matters.
-

Tesamorelin Side Effects: Rates, Risks, Monitoring
The most common tesamorelin side effects are injection-site reactions and joint pain; glucose, IGF-1 and cancer history are the monitoring issues that can change the plan.
Page 1 of 2 · 37 articles